<?xml version="1.0" ?><rss version="2.0"><channel><title>carbogen RSS!</title><link>http://www.carbogen.com</link><description>carbogen creating an RSS feed...</description><item><title>CARBOGEN AMCIS AG Names Dr. Mojmir Vavrecka Chief Operating Officer</title><link>http://www.carbogen-amcis.com</link><description>
<P><I>BUBENDORF, Switzerland</I> - Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has appointed Dr. Mojmir Vavrecka as chief operating officer. In his new role, Dr. Vavrecka will oversee manufacturing activities and technology development.</P></description></item><item><title>CARBOGEN AMCIS AG Makes Capital Investments</title><link>http://www.carbogen-amcis.com/</link><description><EM>BUBENDORF, Switzerland</EM> - Switzerland-based CARBOGEN AMCIS AG has made a number of capital investments this year, with the support of its parent company, Dishman Pharmaceuticals &amp; Chemicals Ltd. Capital expenditures will total $25 million by the end of the fiscal year in April 2009.</description></item></channel></rss>